(NASDAQ: PGNY) Progyny's forecast annual revenue growth rate of 8.28% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.99%.
Progyny's revenue in 2026 is $1,338,672,000.On average, 14 Wall Street analysts forecast PGNY's revenue for 2026 to be $100,454,963,576, with the lowest PGNY revenue forecast at $65,217,660,150, and the highest PGNY revenue forecast at $106,935,928,968. On average, 14 Wall Street analysts forecast PGNY's revenue for 2027 to be $115,258,077,710, with the lowest PGNY revenue forecast at $106,125,808,294, and the highest PGNY revenue forecast at $121,297,159,098.
In 2028, PGNY is forecast to generate $124,022,110,456 in revenue, with the lowest revenue forecast at $112,754,068,354 and the highest revenue forecast at $130,797,665,184.